Spectral Diagnostics EBITDA 2010-2025 | EDTXF

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Spectral Diagnostics ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Spectral Diagnostics ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$184.1B
Intuitive Surgical (ISRG)	$172.5B
IDEXX Laboratories (IDXX)	$51B
Edwards Lifesciences (EW)	$46B
Alcon (ALC)	$43.5B
IQVIA Holdings (IQV)	$32.7B
DexCom (DXCM)	$31.7B
Mettler-Toledo (MTD)	$27B
STERIS (STE)	$24.1B
Waters (WAT)	$17.2B
SONOVA HOLDING (SONVY)	$16.8B
Hologic (HOLX)	$15B
Penumbra (PEN)	$10B
Sysmex ADR (SSMXY)	$8.4B
Masimo (MASI)	$8.4B
Globus Medical (GMED)	$8.1B
Teleflex (TFX)	$5.3B
Glaukos (GKOS)	$5.1B
TransMedics (TMDX)	$4.3B
Integer Holdings (ITGR)	$3.7B
LivaNova (LIVN)	$2.9B
Veracyte (VCYT)	$2.4B
Alphatec Holdings (ATEC)	$2.3B
PROCEPT BioRobotics (PRCT)	$2.3B
Artivion (AORT)	$2B
Nihon Kohden (NHNKY)	$2B
Elekta AB (EKTAY)	$1.8B
OPKO Health (OPK)	$1.1B
Paragon 28 (FNA)	$1.1B
Integra LifeSciences Holdings (IART)	$1.1B